Auriga Research and San Francisco Research Institute Forge Global Alliance for AI-Driven Clinical Trials and Healthcare Innovation
Auriga Research and SFRI partner to advance AI-driven clinical trials and healthcare innovation across global markets. They’ll develop AI platforms and streamline regulatory compliance worldwide.
Auriga Research has entered a strategic partnership with the San Francisco Research Institute (SFRI) to advance clinical research and AI-driven healthcare innovation across multiple global markets. This collaboration focuses on combining Auriga’s operational expertise in India and Asia with SFRI’s market presence and regulatory know-how in the US, Japan, Europe, and Africa.
Integrating AI in Clinical Research and Healthcare Product Development
The partnership targets AI-enhanced clinical trials that improve patient recruitment, monitoring, and real-time data analytics. Both organisations will collaborate on developing electronic Case Report Form (eCRF) systems, digital analytics platforms, and compliance tools tailored for global clinical trials.
They will also co-create AI-powered platforms to support regulatory and market readiness for wellness and pharmaceutical products. This includes joint product development in nutraceuticals and wellness solutions designed for cross-border markets, with particular attention to regulatory and commercial support for products like SNEC30 and Ningen in Africa and the US.
Streamlining Global Regulatory Compliance
The partnership establishes a framework for managing regulatory submissions and ensuring compliance with agencies such as the FDA (USA), EFSA (Europe), and TGA (Australia). It also supports product registrations and public health initiatives in emerging markets including Nigeria.
Dr. Saurabh Arora, Managing Director of Auriga Research, highlights that this partnership expands their global vision for AI-driven clinical research and accessible healthcare solutions. The collaboration aims to streamline innovation pipelines and create new opportunities across diverse geographies while maintaining high standards of quality, ethics, and compliance.
Building Global Competency Through Training
To strengthen expertise in healthcare quality and safety, Auriga and SFRI will launch joint training programs covering Good Clinical Practices (GCP), Good Manufacturing Practices (GMP), Good Laboratory Practices (GLP), and regulatory documentation (GDP). These will be delivered via virtual platforms and on-site workshops, enhancing regulatory excellence and patient-focused innovation worldwide.
Advancing Product Development and Global Funding
The MoU opens doors for joint grant applications and funded research projects aligned with global health initiatives. The alliance plans to co-develop new formulations and health technology solutions, engaging with public health agencies and institutional buyers in key markets.
This collaboration reinforces India’s growing role in the global Contract Research Organisation (CRO) and health-tech export sectors. By combining Auriga’s regional strength with SFRI’s international presence, the partnership sets a strong example of cross-border cooperation in digital health, AI-enabled research, and wellness innovation.
